Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
85.80
+5.79 (7.24%)
Mar 10, 2026, 3:00 PM CST

SHA:688266 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
-2,1542,110797.051,137
Upgrade
Trading Asset Securities
-40.5137.02248.9365.26
Upgrade
Cash & Short-Term Investments
2,0862,1942,2471,0461,202
Upgrade
Cash Growth
-4.91%-2.34%114.79%-12.97%-24.86%
Upgrade
Accounts Receivable
-143.63101.1488.9962.37
Upgrade
Other Receivables
-9.3810.8912.5112.45
Upgrade
Receivables
-153.01112.03101.574.82
Upgrade
Inventory
-182.86110.8598.9851.91
Upgrade
Other Current Assets
-45.8550.7945.377.33
Upgrade
Total Current Assets
-2,5762,5201,2921,406
Upgrade
Property, Plant & Equipment
-363.43271.21247.09188.91
Upgrade
Long-Term Investments
--5.991010
Upgrade
Other Intangible Assets
-50.0169.2791.03116.29
Upgrade
Long-Term Deferred Charges
-11.3916.3920.9613.03
Upgrade
Other Long-Term Assets
-3.884.027.4811.78
Upgrade
Total Assets
-3,0052,8871,6681,746
Upgrade
Accounts Payable
-197.1137.73151.72118.19
Upgrade
Accrued Expenses
-86.2282.0267.548.22
Upgrade
Short-Term Debt
-951.86795.16390.79131.81
Upgrade
Current Portion of Long-Term Debt
-4.9750.5650.0430.03
Upgrade
Current Portion of Leases
-11.213.1713.6913.55
Upgrade
Current Income Taxes Payable
-20.9520.6420.2918.58
Upgrade
Current Unearned Revenue
---0.280.36
Upgrade
Other Current Liabilities
-101.1535.8934.8820.16
Upgrade
Total Current Liabilities
-1,3731,135729.19380.89
Upgrade
Long-Term Debt
-44.35-50.09-
Upgrade
Long-Term Leases
-26.8629.4643.1848.18
Upgrade
Long-Term Unearned Revenue
-9.211.5545.0448.05
Upgrade
Long-Term Deferred Tax Liabilities
-5.79.5813.3215.77
Upgrade
Other Long-Term Liabilities
-292.4556.6--
Upgrade
Total Liabilities
-1,7521,242880.82492.88
Upgrade
Common Stock
-264.71264.71240240
Upgrade
Additional Paid-In Capital
-3,1203,3532,2222,205
Upgrade
Retained Earnings
--2,117-1,979-1,700-1,243
Upgrade
Comprehensive Income & Other
--14.47-5.95-2.84-6.32
Upgrade
Total Common Equity
1,1491,2541,633759.121,196
Upgrade
Minority Interest
--1.2611.9828.3756.76
Upgrade
Shareholders' Equity
1,1491,2531,645787.491,253
Upgrade
Total Liabilities & Equity
-3,0052,8871,6681,746
Upgrade
Total Debt
1,1261,039888.35547.8223.57
Upgrade
Net Cash (Debt)
960.791,1551,358498.18978.32
Upgrade
Net Cash Growth
-16.81%-14.97%172.65%-49.08%-36.78%
Upgrade
Net Cash Per Share
3.654.365.312.084.08
Upgrade
Filing Date Shares Outstanding
264.71264.71264.71264.49240
Upgrade
Total Common Shares Outstanding
264.71264.71264.71240240
Upgrade
Working Capital
-1,2021,385562.571,025
Upgrade
Book Value Per Share
4.344.746.173.164.98
Upgrade
Tangible Book Value
1,1141,2041,564668.091,080
Upgrade
Tangible Book Value Per Share
4.214.555.912.784.50
Upgrade
Buildings
-135.2641.9341.9341.21
Upgrade
Machinery
-145.53120.48121.7496.02
Upgrade
Construction In Progress
-123.47135.8386.6727.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.